Tata India Pharma & Healthcare Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1967 Cr | ₹1325 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.14 | 2.14 |
| Manager | Dhruv Muchhal | Meeta Shetty |
| ISIN Code | INF179KC1HL7 | INF277K016A9 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -0.57% | -1.17% |
| 6 Month | 6% | 3.79% |
| 1 Year | 4.66% | -0.34% |
| 3 Year | - | 21.48% |
| 5 Year | - | 16.15% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | 1.31% | 0.51% |
| 1 Year | 11.15% | 6.3% |
| 3 Year | - | 17.98% |
| 5 Year | - | 17.13% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 27.59% | 8.63% |
| 3 Year | - | 18.84% |
| 5 Year | - | 15.73% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 16.04% |
| Sharp | - | 0.90% |
| Beta | - | 0.97% |
| Alpha | - | -0.83% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhruv Muchhal | Meeta Shetty |
| Total AUM | ₹520687 Cr | ₹17847 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 10.09 | 3.86 |
| Mid Cap | 30.15 | 38.84 |
| Small Cap | 33.66 | 34.36 |
| Large Cap | 26.1 | 22.93 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.71 | 1.5 |
| Basic Materials | 2.86 | 2.17 |
| Healthcare | 95.43 | 96.33 |
| Financial Services | - | 0 |
Top Comparisons
Nippon India Focused Fund - Growth Plan -Growth Option
3Y Returns13.6%
Aditya Birla Sun Life Focused Equity Fund -Growth Option
3Y Returns15.73%
WhiteOak Capital Balanced Advantage Fund Regular Plan Growth
3Y Returns0%
Axis Balanced Advantage Fund - Regular Plan - Growth
3Y Returns13.72%
Canara Robeco Small Cap Fund - Regular Plan - Growth Option
3Y Returns14.56%
Axis Small Cap Fund Regular Growth
3Y Returns16.89%
Canara Robeco Equity Hybrid Fund - Regular Plan - Growth Option
3Y Returns12.9%
Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth
3Y Returns12.97%